Hegde V R, Silver J, Patel M, Gullo V P, Yarborough R, Huang E, Das P R, Puar M S, DiDomenico B J, Loebenberg D
Schering Plough Research Institute, Kenilworth, NJ 07033, USA.
J Antibiot (Tokyo). 2001 Jan;54(1):74-83. doi: 10.7164/antibiotics.54.74.
Two novel antifungal compounds, 1 (SCH 466457), and 2 (SCH 466456), active in a "cell wall" assay, were isolated from the fermentation broth of an unidentified fungus. The active compounds were separated from the broth filtrate by adsorption on a macroreticular resin and were purified on reverse phase HPLC. Detailed mass spectrometric and NMR experiments and degradative studies helped in elucidating the structures of these compounds. The compounds were identified to be peptides containing amino acids such as alanine, aminoisobutyric acid, proline, leucine, valine, glycine and a previously identified beta-keto acid, 2-methyl 3-oxotetradecanoic acid. (5) Both compounds were active against Candida, dermatophytes and Aspergillus (Geometric Mean MIC's, 8.9, 20 and 16 microg/ml, and 64, 128 and 23 microg/ml, respectively for 1 and 2).
从一种未鉴定真菌的发酵液中分离出两种在“细胞壁”检测中具有活性的新型抗真菌化合物,1号化合物(SCH 466457)和2号化合物(SCH 466456)。活性化合物通过吸附在大孔网状树脂上从发酵液滤液中分离出来,并通过反相高效液相色谱法进行纯化。详细的质谱和核磁共振实验以及降解研究有助于阐明这些化合物的结构。这些化合物被鉴定为含有丙氨酸、氨基异丁酸、脯氨酸、亮氨酸、缬氨酸、甘氨酸等氨基酸以及一种先前鉴定的β-酮酸(2-甲基-3-氧代十四烷酸)的肽。(5)两种化合物对念珠菌、皮肤癣菌和曲霉菌均有活性(1号和2号化合物的几何平均最低抑菌浓度分别为8.9、20和16微克/毫升,以及64、128和23微克/毫升)。